Control your neurons to eat healthily

Obesity and overweight are aesthetic and health problems that affect a large part of the Mexican population, both adults and children. This situation has led to the creation of treatments aimed at controlling this condition, which, according to figures from the World Health Organization , it costs the life to 2, 8 million people every year.

Among the most used options for the treatment of obesity and overweight is the use of anorexigenic drugs, which, primarily, modulate neuronal activity.

The majority of the medicines that are in the market are anorexigenic, except the orlistat that produces a diminution in the absorption of the nutrients. Among the most common is sibutramine.

Sibutramine is a drug that inhibits the receptor of noradrenaline, serotonin and dopamine, producing an anorectic effect. It is biotransformed into two active metabolites that act for weight loss. Among its adverse reactions are nausea, insomnia and blood pressure.

If you want to know a little more about the methods that exist to control the neurons and, consequently, your appetite, GetQoralHealth and the specialist in Neurobiology of Appetite, Ranier Gutiérrez, they present you the following video.

Other drugs that are used in the treatment of obesity and overweight are:

Metformin It is an antihyperglycemic agent that decreases the production of hepatic glucose, increases the action of insulin in muscles and fat, without modifying the release of insulin, and reduces the absorption of glucose in the intestine.

Thermogenic It is a medication that helps burn fat and improve metabolism.

However, losing weight is not a unique issue of drugs. It is also necessary for the person to change their eating habits and add a routine of 30 minutes of exercise daily.

Follow us at @GetQoralHealth, GetQoralHealth on Facebook and YouTube! Want to lose weight? Sign up with us and enjoy the new GetQoralHealth tool


Video Medicine: Food for thought: How your belly controls your brain | Ruairi Robertson | TEDxFulbrightSantaMonica (May 2024).